Jennifer Michaelson sold $608K of Cullinan Therapeutics (CGEM)

Executed Aug 13, disclosed Aug 14, 1 day later.

Value, as filed

$608K

30,000 sh × $20.26

Executed

Aug 13

the trade date, as filed

Disclosed

Aug 14

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jennifer Michaelson Chief Scientific Officer profile →

Jennifer Michaelson (Chief Scientific Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Cullinan Therapeutics, Inc. (CGEM). The largest single filing was $608K of CGEM (30,000 sh × $20.26, as filed), executed Aug 13.

The name

CGEM

Cullinan Therapeutics, Inc. CGEM · Healthcare · 13 filings in 24 months ticker →

Healthcare · Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the Unite…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jennifer Michaelson in CGEM

CGEMSALE Cullinan Therapeutics, Inc. $173K
8,000 sh × $21.57
Exec Sep 8
Filed Sep 10 · 9:22 AM ET CGEMSALE Cullinan Therapeutics, Inc. $143K
8,000 sh × $17.82
Exec Jul 6
Filed Jul 7 · 5:00 PM ET CGEMSALE Cullinan Therapeutics, Inc. $114K
7,800 sh × $14.60
Exec May 5
Filed May 6 · 5:30 PM ET CGEMSALE Cullinan Therapeutics, Inc. $125K
8,000 sh × $15.68
Exec Mar 5
Filed Mar 9 · 5:30 PM ET CGEMSALE Cullinan Therapeutics, Inc. $114K
8,000 sh × $14.30
Exec Feb 20
Filed Feb 23 · 5:30 PM ET CGEMSALE Cullinan Therapeutics, Inc. $125K
8,000 sh × $15.64
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET CGEMSALE Cullinan Therapeutics, Inc. $145K
8,000 sh × $18.09
Exec Sep 5 2024
Filed Sep 9 2024 · 5:30 PM ET